Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Safety and Efficacy of Octreotide LAR in Treatment Naïve Acromegalic Patients

NCT00128232 is registered in ClinicalTrials.gov with Novartis as lead sponsor.

NCT NCT00128232
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00128232 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Safety and Efficacy of Octreotide LAR in Treatment Naïve Acromegalic Patients
Lead sponsor
Novartis
Phase
Phase 3
Overall status
Completed
Start date
December 31, 2002
Completion date
Not reported
Enrollment
100
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

acromegaly